Serina Therapeutics
在场
Serina Therapeutics 的所有者是 Lineage Cell Therapeutics.
是其中之一......
Lineage Cell Therapeutics 是一家在股票代码 LCTX (US) 下上市的公司。
高管
查看带有其 13 名主要高管的组织结构图
Serina Therapeutics 搜索最多的简介
- Steve Ledger, Chief Executive Officer and Director
- Richard Marshall, Director
- Karen Wilson, Director
高管在Serina Therapeutics变化
- Jay Venkatesan已作为Director加入公司 (新闻发布的2025二月13号).
- Karen Wilson已作为Director加入公司 (新闻发布的2025一月15号).
- Tacey Viegas, Chief Operating Officer, 正在办理退休 (新闻发布的2024七月22号).
创建提醒
跟踪 Serina Therapeutics 的高管变动
生物技术
Lineage Cell Therapeutics 拥有 2,344 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Metir的新名称是Metir。 (公布2025二月14号).
- Stellaromics 刚刚宣布为 80 筹款数百万美元。 (公布2025二月12号).
- Sionna Therapeutics 已提交其 IPO 档案。它的股票代码将是 SION。 (公布2025二月10号).
生物技术 行业的其他推荐联系人
消息
Serina Therapeutics 的最新新闻稿
- Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit
- Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024
- Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients
- Serina Therapeutics Makes Grants to New Employees Under Inducement Plan
- Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
- Serina Therapeutics to Present at the 14th Annual Injectables Summit
- Enable Injections Announces Agreement with Sobi® to Develop and Distribute Aspaveli® in Combination with enFuse® in Sobi Territories
- Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics Summit
- Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
- View more press releases Close
